Updates
GENEGUT Synergies: Advancing Oral Site-Specific Delivery Through Academic–Industry Collaboration
The GENEGUT project exemplifies the strength of academic–industry collaboration, bringing together Lonza Capsules & Health Ingredients (Lonza) and the drug delivery group in the School of Pharmacy at University College Cork (UCC).
PostDoc position in GENEGUT
The GENEGUT consortium is currently looking for an exceptionally enthusiastic, creative, and driven Post-Doctoral Researcher with a passion for interdisciplinary science.
GENEGUT Behind the Scenes: Bangor University
Welcome to the first edition of our “GENEGUT: Behind the Scenes” campaign — a series that shines a light on the dedicated teams behind GENEGUT. Each article features one of our partners and showcases their unique role, contributions, and passion driving this EU-funded project forward.
GENEGUT Synergies: Collaboration across GENEGUT partners advances development of RNA-based nanoparticles for oral delivery to treat Crohn’s disease
Collaboration between partners at Cork University and Uppsala University has resulted in a robust system to investigate the interactions between the NPs formulated and 3D ileal organoids, as well as monitoring delivery efficiency and intracellular trafficking.
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
RECAP: GENEGUT Seminar with Driton Vllasaliu, Engineered milk extracellular vesicles for oral delivery of RNA
New GENEGUT publication: Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease
We are happy to announce that our new GENEGUT publication “Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease” is now available to read online.
UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).